Skip to Content

Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

(0 review)
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.
1,234,567.00 € 1,234,567.00 € (Tax excluded)

0.00 € / Units
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: GMA-CD3E
Display Name: [GMA-CD3E] Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific